78
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ATICLE

Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: Still looking for a marker of treatment efficacy

, , , &
Pages 1028-1032 | Received 18 Apr 2006, Published online: 08 Jul 2009

References

  • Ploug M. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor. Current Pharmaceutical Design 2003; 9: 1499–528
  • Nykjaer A, Moller B, Todd RF, Christensen T, Andreasen PA, Gliemann J, et al. Urokinase receptor: an activation antigen in human T-lymphocytes. Journal of Immunology 1994; 152: 505–16
  • Plesner T, Ralfkiaer E, Wittrup M, Johnsen H, Pyke C, Pedersen TL, et al. Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and haematopoietic tissue. American Journal of Clinical Pathology 1994; 102: 835–41
  • Coleman JL, Gebbia JA, Benach JL. Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87). Journal of Immunology 2001; 166: 473–80
  • Coleman JL, Benach JL. The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system. Infection and Immunity 2003; 71: 5556–64
  • Dekkers PEP, ten Hove T, Te Velde AA, van Deventer SJH, van der Poll T. Up-regulation of monocyte urokinase plasminogen activator receptor during human endotoxaemia. Infection and Immunity 2000; 68: 2156–60
  • Juffermans NP, Dekkers REP, Verbon A, Speelman P, van Deventer SJH, van der Poll T. Concurrent up-regulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxaemia. Infection and Immunity 2001; 69: 5182–5
  • Kirchheimer JC, Nong YH, Remold HG. Ifn-gamma, tumour necrosis factor-alpha, and urokinase regulate the expression of urokinase receptors on human monocytes. Journal of Immunology 1988; 141: 4229–34
  • Sitrin RG, Todd RF, Mizukami IF, Gross TJ, Shollenberger SB, Gyetko MR. Cytokine-specific regulation of urokinase receptor (Cd87) expression by U937 mononuclear phagocytes. Blood 1994; 84: 1268–75
  • Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 2002; 6: 686–92
  • Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H. Soluble urokinase receptor levels in plasma during 5 y of highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 2004; 35: 337–42
  • Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, et al. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumour tissue from patients with primary breast cancer. Clinical Cancer Research 2002; 8: 1132–41
  • Riisbro R, Piironen T, Brunner N, Larsen B, Nielsen HJ, Stephens RW, et al. Measurement of soluble urokinase plasminogen activator receptor in serum. Journal of Clinical Ligand Assay 2002; 25: 53–6
  • Kjelsø C, Andersen P. Tuberkulose 2004. Epi-news, week 49.
  • Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nature Reviews Molecular Cell Biology 2002; 3: 932–43
  • Almus-Jacobs F, Varki N, Sawdey MS, Loskutoff DJ. Endotoxin stimulates expression of the murine urokinase receptor gene in vivo. Am J Pathol 1995; 147: 688–98
  • Romer J, Lund LR, Eriksen J, Pyke C, Kristensen P, Dano K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. J Invest Dermatol 1994; 102: 519–22
  • Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, et al. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996; 2: 287–92
  • Solberg H, Ploug M, Hoyer-Hansen G, Nielsen BS, Lund LR. The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodelling. J Histochem Cytochem 2001; 49: 237–46
  • de Bock CE, Wang Y. Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer. Medicinal Research Reviews 2004; 24: 13–39

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.